Trials / Completed
CompletedNCT01634321
The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
The Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty; A Single, Open, Multi-center, Prospective Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 4 Years – 9 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this Clinical Trial was to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide acetate 3.75mg) in patients with precocious puberty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Luphere depot 3.75mg(Leuprolide acetate 3.75mg) |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2012-07-06
- Last updated
- 2014-08-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01634321. Inclusion in this directory is not an endorsement.